Concepedia
Statistics
Publications
44
Citations
1.6K
H-Index
24
Active since
2003
Affiliations
Institute of Hematology & Blood Diseases Hospital(Current)
Chinese Academy of Medical Sciences & Peking Union Medical College
Harbin Medical University
The University of Texas MD Anderson Cancer Center
Soochow University
Yingchang Mi is an author at Institute of Hematology & Blood Diseases Hospital specializing in medicine, oncology, and hematology.
Publications per year
2003–2025
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
Qi Zhang, Bridget Riley‐Gillis, Lina Han et al. · Signal Transduction and Targeted Therapy · 2022 · 181 citations · Full text
Medicine, Cancer Biology, Oncology +17
Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial
Jie Jin, Jianxiang Wang, Feifei Chen et al. · The Lancet Oncology · 2013 · 160 citations
Medicine, Hematology, Pharmacology +10
Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
Runxia Gu, Fang Liu, Dehui Zou et al. · Journal of Hematology & Oncology · 2020 · 112 citations · Full text
Life Sciences, Immunology, Oncology +17
Apoptosis in Leukemia Cells Is Accompanied by Alterations in the Levels and Localization of Nucleolin
Yingchang Mi, Shelia D. Thomas, Xiaohua Xu et al. · Journal of Biological Chemistry · 2003 · 102 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +16
TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia
Yirui Chen, Shouyun Li, Chunlin Zhou et al. · Blood · 2014 · 67 citations · Full text
Medicine, Molecular Biology, Molecular Genetics +11
1–5 of 44